| Literature DB >> 20047686 |
Gianfranco Damiani1, Luigi Pinnarelli, Simona C Colosimo, Roberta Almiento, Lorella Sicuro, Rocco Galasso, Lorenzo Sommella, Walter Ricciardi.
Abstract
BACKGROUND: Clinical practice guidelines have been developed aiming to improve the quality of care. The implementation of the computerized clinical guidelines (CCG) has been supported by the development of computerized clinical decision support systems.This systematic review assesses the impact of CCG on the process of care compared with non-computerized clinical guidelines.Entities:
Mesh:
Year: 2010 PMID: 20047686 PMCID: PMC2837004 DOI: 10.1186/1472-6963-10-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Description of 21 CCG's features in five categories and proportion# of study containing each feature
| CATEGORY | FEATURE | EXPLANATION | PROPORTION |
|---|---|---|---|
| User has access to recommendation in computer terminals, available at several workstations in the hospital. | 0.20 | ||
| Recommendation is provided in different ways including reminders of overdue health care tasks, alerts of critical values, prompts for various active care issues. | 0.78 | ||
| Software designer or producer is involved in the design of study. | 0.38 | ||
| User automatically receives prompts (complete automation) instead of active initiation of the system by user (incomplete automation). | 0.80 | ||
| Recommendations printed on paper forms and attached to patient charts by clinical support staff, so that clinicians do not need to look for the computer advice. | 0.29 | ||
| Electronic recommendations linked to patient charts display automatically to clinicians when a clinician accesses the database. | 0.82 | ||
| Data of patient are updated via network link to servers storing information about all contacts of patient with the hospital. | 0.33 | ||
| The user is asked to justify the decision of disagreement with a reason such as "the patient refused" or "I disagree with the recommendation". | 0.56 | ||
| Recommendations provided as chart reminders during an encounter, rather than as monthly reports listing all the patients in need of services. | 0.13 | ||
| Computerised system provides recommendations in response to an order and the user simply clicks "OK" to order the recommended tests. | 0.11 | ||
| Systems show better actions to perform, rather than simply providing a diagnosis. | 0.11 | ||
| Systems recommend an alternative view, rather than simply recommending the order to be cancelled. | 0.11 | ||
| Recommendation for a check justified by noting date of last exam and recommended frequency of testing. | 0.18 | ||
| Recommendation design finalised after testing preliminary versions of software (beta version) with representatives from targeted user group. | 0.09 | ||
| As well as providing chart reminders for clinicians, system generates postcards that are sent to patients to inform them of existing recommendation. | 0.18 | ||
| Users are sent e-mails periodically that summarise users compliance with recommendations. | 0.02 | ||
| Implementation of a recommendation is accompanied by a presentation or an appropriate explanation for following such suggestion. | 0.27 | ||
| A training period is provided for users to experience the basic features of the software. | 0.22 | ||
| Recommendations are focused on preventive or treatment issues or both options. | 0.31 | ||
| Recommendations are oriented towards acute or chronic patients or both options. | 0.16 | ||
| Recommendations suggest to administrate tests or/and drugs to patients or to perform other type of intervention on them or both options. | 0.53 | ||
** Feature referring to Kawamoto
* Feature selected by authors
# Calculated on the total of 45 studies
Study design and quality assessment of selected articles
| Quality assessment | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Burack | 1997 | Medical Care | Experimental | 2 | 2 | 2 | 2 | 2 | |
| Burack | 1994 | Medical Care | Experimental | 2 | 2 | 2 | 2 | 2 | |
| Butzlaff | 2003 | Family Practice | Experimental | 2 | 1 | 2 | 0 | 2 | |
| Cannon | 2000 | JAMIA | Experimental | 2 | 2 | 2 | 1 | 2 | |
| Carton | 2002 | Clinical Radiology | Observational (time series) | 0 | 1 | 0 | 2 | 2 | |
| Dayton | 2000 | Medical Decision Making | Experimental | 2 | 1 | 0 | 0 | 2 | |
| Demakis | 2000 | JAMA | Experimental | 2 | 2 | 2 | 2 | 2 | |
| Derose | 2005 | American Journal Manag Care | Experimental | 2 | 1 | 0 | 2 | 2 | |
| Dexter | 2001 | New England Journal of Medicine | Experimental | 2 | 2 | 2 | 2 | 2 | |
| Durieux | 2000 | JAMA | Observational (time series) | 0 | 1 | 1 | 2 | 2 | |
| Feldman | 2005 | Health Services Research | Experimental | 1 | 1 | 2 | 1 | 2 | |
| Feldstein | 2006 | Journal American Geriatric Soc | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Filippi | 2003 | Diabetes Care | Experimental | 2 | 1 | 0 | 2 | 2 | |
| Fitzamaurice | 2000 | Arch Intern Med | Experimental | 2 | 1 | 2 | 1 | 2 | |
| Frank | 2004 | Australia | Experimental | 1 | 1 | 2 | 2 | 2 | |
| Hetlevik | 1999 | Scand J Health Care | Experimental | 2 | 1 | 2 | 2 | 1 | |
| Hetlevik | 2000 | Int J Technol Assess Health Care | Experimental | 2 | 1 | 2 | 2 | 0 | |
| Jousimaa | 2002 | Int J Technol Assess Health Care | Experimental | 2 | 1 | 2 | 2 | 1 | |
| Kitahata | 2003 | Clinical Infectious Disease | Observational (before and after) | 0 | 1 | 2 | 2 | 2 | |
| Kucher | 2005 | The New England Journal of medicine | Experimental | 2 | 1 | 0 | 2 | 2 | |
| Lafata | 2002 | JGIM | Experimental | 2 | 2 | 2 | 2 | 2 | |
| Lobach | 1997 | Am J Med | Experimental | 2 | 0 | 2 | 2 | 2 | |
| Raebel | 2005 | Arch Intern Med | Experimental | 2 | 1 | 2 | 2 | 2 | |
| McCowan | 2001 | Medical Informatics | Experimental | 2 | 2 | 2 | 1 | 0 | |
| McMullin | 2004 | Annals of Family Medicine | Observational (retrospective cohort study) | 0 | 1 | 0 | 2 | 2 | |
| Medow | 2001 | Medical Decision Making | Experimental | 2 | 2 | 0 | 0 | 2 | |
| Meigs | 2003 | Diabetes Care | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Montgomery | 2000 | BMJ | Experimental | 2 | 2 | 2 | 1 | 1 | |
| Mosen | 2004 | Chest | Observational (before and after) | 0 | 2 | 2 | 2 | 2 | |
| Murtaugh | 2005 | Health Services Research | Experimental | 2 | 1 | 2 | 1 | 2 | |
| Overhage | 1996 | Arch Intern Med | Experimental | 1 | 2 | 2 | 2 | 2 | |
| Overhage | 1997 | JAMIA | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Poller | 1993 | J Clin Pathol | Experimental | 2 | 2 | 1 | 2 | 2 | |
| Rood | 2005 | JAMIA | Experimental | 2 | 2 | 1 | 2 | 2 | |
| Rossi | 1997 | JGIM | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Safran | 1995 | Lancet | Experimental | 0 | 2 | 2 | 2 | 2 | |
| Schriger | 1997 | JAMA | Observational (interrupted time series) | 1 | 1 | 2 | 2 | 2 | |
| Sequist | 2005 | JAMIA | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Shojonia | 1998 | JAMIA | Experimental | 2 | 2 | 0 | 2 | 2 | |
| Steele | 2005 | American Journal of Preventive Medicine | Experimental | 0 | 1 | 0 | 2 | 2 | |
| Thomas | 1999 | J Med Internet Res | Experimental | 2 | 1 | 0 | 1 | 2 | |
| Tierney | 2003 | JGIM | Experimental | 2 | 1 | 2 | 2 | 2 | |
| Turner | 1994 | Arch Intern Med | Experimental | 2 | 1 | 2 | 2 | 1 | |
| Williams | 1998 | Arch Fam Med | Experimental | 2 | 1 | 0 | 2 | 2 | |
| Zanetti | 2003 | Infection control and hospital epidemiology | Experimental | 2 | 2 | 2 | 2 | 2 | |
Figure 1Selection process of studies on computerized guidelines.
Characteristics of selected studies.
| Variables | Countries | |||
|---|---|---|---|---|
| Observational | 2 (33.3%) | 4 (66.7%) | 0 (0.0%) | |
| Experimental | 9 (23.1%) | 29 (74.3%) | 1 (2.6%) | |
| Inpatient | 2 (28.6%) | 5 (71.4%) | 0 (0.0%) | |
| Outpatient | 4 (23.5%) | 12 (70.6%) | 1 (5.9%) | |
| Physicians | 10(28.6%) | 24 (68.6%) | 1 (2.9%) | |
| Other care givers | 1 (10.0%) | 9 (90.0%) | 0 (0%) | |
| Simulated | 1 (25.0%) | 3 (75.0%) | 0 (0.0%) | |
| Real | 10(24.4%) | 30 (73.2%) | 1 (3.3%) | |
| Non--academic | 5 (22.7%) | 17 (77.3%) | 0 (0.0%) | |
| Academic | 5 (25.0%) | 15 (75.0%) | 0 (0.0%) | |
| Multicentric | 7 (36.8%) | 11 (57.9%) | 1 (5.3%) | |
| Monocentric | 4 (15.4%) | 22 (84.6%) | 0 (0.0%) | |
| Preventive | 1 (7.1%) | 12 (85.7%) | 1 (7.1%) | |
| Treatment | 9 (32.1%) | 19 (67.9%) | 0 (0.0%) | |
| Both | 1 (33.3%) | 2 (66.7%) | 0 (0.0%) | |
| Acute | 2 (28.6%) | 5 (71.4) | 0 (0.0%) | |
| Chronic | 6 (22.2%) | 21 (77.8%) | 0 (0.0%) | |
| Both | 3 (27.3%) | 7 (63.6%) | 1 (9.1%) | |
| Test or/and drugs | 7 (29.2%) | 17 (70.8%) | 0 (0.0%) | |
| Other intervention | 1 (14.3%) | 6 (85.7%) | 0 (0.0%) | |
| Both | 3 (21.4%) | 10 (71.4) | 1 (7.1%) | |
Figure 2Plot of the effect stratified by ".